MNOV - MediciNova - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MNOV is currently covered by 2 analysts with an average price target of $7.5. This is a potential upside of $5.59 (420.83%) from yesterday's end of day stock price of $1.44.

MediciNova's activity chart (see below) currently has 5 price targets and 16 ratings on display. The stock rating distribution of MNOV is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for MNOV is $9, Lowest price target is $6, average price target is $7.5.

Most recent stock forecast was given by from D. BORAL CAPITAL on 04-May-2026. First documented stock forecast 25-Mar-2019.

Best performing analysts who are covering MNOV - MediciNova:

Jason Kolbert Chad Mabry Jason Mccarthy

Currently out of the existing stock ratings of MNOV, 9 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 02-Dec-2024

$9

$7.68 (581.82%)

2 months 4 days ago
(04-May-2026)

0/4 (0%)

$7.6 (542.86%)

Buy Since 10-Mar-2021

$6

$4.68 (354.55%)

$6

3 months 15 days ago
(23-Mar-2026)

0/3 (0%)

$4.55 (313.79%)

Buy Since 25-Mar-2019

$5

$3.62 (262.32%)

$22

1 years 22 days ago
(16-Jun-2025)

0/2 (0%)

$3.67 (275.94%)

Show more analysts

Please expand the browser size to see the chart

What is MNOV (MediciNova) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on MNOV (MediciNova) with a proven track record?

JASON KOLBERT

Which analyst has the most public recommendations on MNOV (MediciNova)?

Jason Kolbert works at D. BORAL CAPITAL and has 4 price targets and 3 ratings on MNOV

Which analyst is the currently most bullish on MNOV (MediciNova)?

Jason Kolbert with highest potential upside - $7.68

Which analyst is the currently most reserved on MNOV (MediciNova)?

Chad Mabry with lowest potential downside - $3.62

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?